Marchiafava Bignami disease
Prevalence estimates on Rare Medical Network websites are calculated based on data available from numerous sources, including US and European government statistics, the NIH, Orphanet, and published epidemiologic studies. Rare disease population data is recognized to be highly variable, and based on a wide variety of source data and methodologies, so the prevalence data on this site should be assumed to be estimated and cannot be considered to be absolutely correct.
Age of Onset
Autosomal dominant ?A pathogenic variant in only one gene copy in each cell is sufficient to cause an autosomal dominant disease
Autosomal recessive ?Pathogenic variants in both copies of each gene of the chromosome are needed to cause an autosomal recessive disease and observe the mutant phenotype
X-linked dominant ?X-linked dominant inheritance, sometimes referred to as X-linked dominance, is a mode of genetic inheritance by which a dominant gene is carried on the X chromosome.
X-linked recessive ?Pathogenic variants in both copies of a gene on the X chromosome cause an X-linked recessive disorder
Mitochondrial or multigenic ?Mitochondrial genetic disorders can be caused by changes (mutations) in either the mitochondrial DNA or nuclear DNA that lead to dysfunction of the mitochondria and inadequate production of energy.
Multigenic or multifactor ?Inheritance involving many factors, of which at least one is genetic but none is of overwhelming importance, as in the causation of a disease by multiple genetic and environmental factors.
Other Names (AKA)
MBD; Chronic Marchiafava-Bignami syndrome; Acute Marchiafava-Bignami disease
Nervous System Diseases
Marchiafava Bignami disease is defined by characteristic demyelination of the
Support and advocacy groups can help you connect with other patients and families, and they can provide valuable services. Many develop patient-centered information and are the driving force behind research for better treatments and possible cures. They can direct you to research, resources, and services. Many organizations also have experts who serve as medical advisors or provide lists of doctors/clinics. Visit the group’s website or contact them to learn about the services they offer. Inclusion on this list is not an endorsement by GARD.
National Organization of Disorders of the Corpus Callosum
18032-C Lemon Drive
Yorba Linda, CA 92886
These resources provide more information about this condition or associated symptoms. The in-depth resources contain medical and scientific language that may be hard to understand. You may want to review these resources with a medical professional.
- Medscape Reference provides information on this topic. You may need to register to view the medical textbook, but registration is free.
- The Monarch Initiative brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch’s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.
- Orphanet is a European reference portal for information on rare diseases and orphan drugs. Access to this database is free of charge.
- PubMed is a searchable database of medical literature and lists journal articles that discuss Marchiafava Bignami disease. Click on the link to view a sample search on this topic.
- LEE GOLDMAN, DENNIS AUSIELLO. Cecil Medicine, 23rd ed. USA: Saunders Elsevier; 2007;
- Jennifer Ault. Marchiafava-Bignami Disease. Medscape Reference. October 6, 2014; https://emedicine.medscape.com/article/1146086-overview#showall.
- Walter G. Bradley et al. Neurology in Clinical Practice, 5th ed.. USA: Butterworth-Heinemann; 2008 ;
- Saumitra Shankar Nemlekar, Ritambhara Yeshwant Mehta, Kamlesh Rushikray Dave, and Nilima Deepak Shah. Marchiafava: Bignami Disease Treated with Parenteral Thiamine.. Indian J Psychol Med. 2016 Mar-Apr; 38(2):147--149. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820555/.
- Kumar N. Neurologic presentations of nutritional deficiencies. Neurol Clin. February 2010; 28(1):107-170. https://www.ncbi.nlm.nih.gov/pubmed/19932379.